No Data
Evome Medical Technologies Announces Securities Issuances
EVOME MED TECHNOLOGIES INC | 6-K: Report of foreign private issuer (related to financial reporting)
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt Is Cancelled
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
Evome Medical Technologies Punctuates Turn Around Plan With Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors
No Data
